Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00488709 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Topotecan
DRUG: Fludarabine
DRUG: Cytarabine

Sponsor

PETHEMA Foundation